National Health Investors, Inc. (NHI) to Distribute Quarterly Dividend of $0.92 on August 7th

National Health Investors, Inc. (NYSE:NHI) declared a quarterly dividend on Monday, May 4th. Shareholders of record on Tuesday, June 30th will be paid a dividend of 0.92 per share by the real estate investment trust on Friday, August 7th. This represents a c) annualized dividend and a yield of 4.7%. The ex-dividend date is Tuesday, June 30th.

National Health Investors has decreased its dividend by an average of 0.0%per year over the last three years. National Health Investors has a dividend payout ratio of 112.5% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Research analysts expect National Health Investors to earn $5.11 per share next year, which means the company should continue to be able to cover its $3.68 annual dividend with an expected future payout ratio of 72.0%.

National Health Investors Trading Up 1.5%

NYSE NHI opened at $77.58 on Friday. The business’s 50-day moving average price is $74.89 and its two-hundred day moving average price is $79.64. National Health Investors has a 12 month low of $67.94 and a 12 month high of $91.38. The firm has a market capitalization of $3.76 billion, a PE ratio of 25.02, a price-to-earnings-growth ratio of 4.21 and a beta of 0.52. The company has a current ratio of 8.20, a quick ratio of 8.20 and a debt-to-equity ratio of 0.83.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Monday, May 4th. The real estate investment trust reported $0.82 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.39). National Health Investors had a return on equity of 9.82% and a net margin of 36.86%.The company had revenue of $115.13 million for the quarter, compared to the consensus estimate of $70.22 million. During the same quarter last year, the business earned $1.15 earnings per share. National Health Investors’s revenue was up 28.9% compared to the same quarter last year. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, analysts expect that National Health Investors will post 4.87 EPS for the current year.

Insider Buying and Selling

In other news, CEO D. Eric Mendelsohn acquired 1,500 shares of the firm’s stock in a transaction dated Friday, June 5th. The stock was purchased at an average price of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the acquisition, the chief executive officer directly owned 133,316 shares in the company, valued at $9,177,473.44. The trade was a 1.14% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Robert A. Mccabe, Jr. bought 890 shares of the stock in a transaction dated Monday, June 15th. The shares were purchased at an average cost of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the transaction, the director directly owned 44,159 shares of the company’s stock, valued at $3,163,992.35. This trade represents a 2.06% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Company insiders own 2.70% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Norges Bank bought a new stake in shares of National Health Investors during the fourth quarter worth about $55,301,000. Freestone Grove Partners LP bought a new position in National Health Investors in the 4th quarter valued at about $21,869,000. Adage Capital Partners GP L.L.C. bought a new position in National Health Investors in the 4th quarter valued at about $19,856,000. Balyasny Asset Management L.P. boosted its stake in National Health Investors by 66.9% during the 2nd quarter. Balyasny Asset Management L.P. now owns 614,960 shares of the real estate investment trust’s stock valued at $43,121,000 after purchasing an additional 246,486 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in National Health Investors by 481.3% during the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 236,383 shares of the real estate investment trust’s stock valued at $18,792,000 after purchasing an additional 195,716 shares during the last quarter. 62.51% of the stock is owned by institutional investors.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.